Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.
Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check15 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for data download options, including formats like CSV, JSON, and FHIR, while removing several key government health-related links.SummaryDifference14%
- Check36 days agoChange DetectedNew links have been added to the website, including major health and government resources such as HHS, NIH, and USA.gov.SummaryDifference0.7%
- Check44 days agoChange DetectedThe website has updated the entry for the Phase II trial of Pyrotinib in combination with neoadjuvant chemotherapy in HR+/HER2-, HER4 high expression breast cancer patients, moving from revision v2.12.1 to v2.12.2, while the previous version has been removed.SummaryDifference17%
- Check51 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.